A

ALS Investment Fund

6 employees

The ALS Investment Fund supports and finances biotech companies

Investor insights

Sectors invested in

Biotechnology7
Health Care5
Medical3
Life Science3
Pharmaceutical3
Genetics2
ALS2
Neuroscience2
Orphan Drugs1
Personalized Health1
Understanding Disease1
Precision Medicine1
Emulating Human Biology1
Biopharma1
Machine Learning1
Health Diagnostics1
Therapeutics1
Heat-Shock Protein1
Protein-Misfolding1
Orphan Diseases1

Funding rounds participated in

$36M sweet spot round size

Most of their 7 investments are in rounds between $12M and $42M

Basic info

Industry

biotechnology research

Sectors

neurodegenerative disease
Biotech
Venture capital
ALS
Impact investing

Date founded

2016

Investments made

V

Verge Genomics raised $98M on December 16, 2021

Investors: Section 32, Lifeforce Capital, Alumni Ventures Group, Vulcan Capital, Threshold Ventures, Tao Capital Partners and ALS Investment Fund

B

Bloom Science, Inc. raised $12M on December 9, 2021

Investors: Joyance Partners, Apollo Ventures, Leaps by Bayer and ALS Investment Fund

P

Prilenia raised $43M on November 3, 2021

Investors: Sectoral Asset Management, Amplitude Ventures, Sands Capital Management, Morningside Venture Partners, Forbion and ALS Investment Fund

A

Apic Bio, Inc. raised $42M on January 7, 2019

Investors: Morningside Venture Capital 晨兴资本 and ALS Investment Fund

E

Emulate, Inc. raised $36M on June 18, 2018

Investors: Starlight Ventures, GlassWall Syndicate, SciFi VC, Beyond Impact VC, Founders Fund and ALS Investment Fund

O

Orphazyme A/S raised $15M on March 8, 2017

Investors: Aescap, Novo Holdings, Idinvest Partners, Sunstone Life Science Ventures and ALS Investment Fund

A

Amylyx Pharmaceuticals raised $5M on August 22, 2016

Investors: Lysosomal Therapeutics Inc. and ALS Investment Fund

FAQ